Market Tracker

10/24 7:48am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

54.13
Data as of Oct 23
 +3.46 / +6.83%
Today’s Change
41.99
Today|||52-Week Range
80.42
+2.91%
Year-to-Date

Today’s Trading

Previous close50.67
Today’s open51.79
Day’s range-- - --
Volume496,468
Average volume (3 months)435,727
Market cap$1.1B
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+70.74%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio150.4
Price/Sales21.82
Price/Book20.90

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...+0.16+1.45%
SGNTSagent Pharmaceutica...+0.81+2.54%
CMRXChimerix Inc+1.45+4.74%
KPTIKaryopharm Therapeut...+1.52+4.52%
Data as of 10/23/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts